NL47891C - - Google Patents

Info

Publication number
NL47891C
NL47891C NL47891DA NL47891C NL 47891 C NL47891 C NL 47891C NL 47891D A NL47891D A NL 47891DA NL 47891 C NL47891 C NL 47891C
Authority
NL
Netherlands
Application number
Publication of NL47891C publication Critical patent/NL47891C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
NL47891D NL47891C (xx)

Publications (1)

Publication Number Publication Date
NL47891C true NL47891C (xx)

Family

ID=1807212

Family Applications (1)

Application Number Title Priority Date Filing Date
NL47891D NL47891C (xx)

Country Status (1)

Country Link
NL (1) NL47891C (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5333774A (en) * 1992-03-16 1994-08-02 Hitachi Techno. Engineering Co., Ltd. Vapor reflow soldering apparatus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5333774A (en) * 1992-03-16 1994-08-02 Hitachi Techno. Engineering Co., Ltd. Vapor reflow soldering apparatus

Similar Documents

Publication Publication Date Title
AP718A (en) A controlled-release pharmaceutical formulation for oral administration.
AP802A (en) Rapidly releasing and taste-masking pharmaceutical dosage form.
AP2815A (en) Compositions comprising nebivolol
AP2002002648A0 (en) Fast dissolving orally consumable films containing an ion exhange resin as a taste masking agent.
AP2001002288A0 (en) Methods for treatment of sickle cell anemia.
AP2010005341A0 (en) Solid pharmaceutical dosage form
AP2001002237A0 (en) Hydrogel-driven drug dosage form.
AP841A (en) Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection.
AP2002002410A0 (en) Hydrodynamically Balancing Oral Drug Delivery System
AP2007004065A0 (en) Targeted iron chelator delivery system
AP3803A (en) Pharmaceutical dosage form
AP2003002763A0 (en) Controlled release formulations for oral administration
AP3151A (en) Stable ready to use injectable paracetamol formulation
AP2006003602A0 (en) Oral drug delivery system
AP2006003703A0 (en) Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
AP3204A (en) A controlled release intravaginal polymeric pharmaceutical dosage form
AP2008004482A0 (en) Patch
AP827A (en) Pharmaceutical preparation with trypanocidal qualities for veterinary use.
AP1065A (en) Topical preparation for introducing peptidaceous pharmacons in living organisms.
AP858A (en) Process for preparing solid dosage forms of very low-dose drugs.
AP2343A (en) Rapidly disintegrating taste-masked tablet.
AP2007004156A0 (en) Composition containing chitosan for sustained drugrelease
AP86A (en) Implant
AP2014007934A0 (en) Taste masked dispersible tablets
AP2006003704A0 (en) Controlled release pharmaceutical composition comprising an acid insoluble polymer and a bioadhesivepolymer